http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#Head
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#provenance
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#pubinfo
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion
http://purl.obolibrary.org/obo/DOID_9700
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9700
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB06771
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
http://www.w3.org/2000/01/rdf-schema#label
besivance tm besifloxacin ophthalmic suspension 6 is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria cdc coryneform group g corynebacterium pseudodiphtheriticum corynebacterium striatum haemophilus influenzae moraxella lacunata staphylococcus aureus staphylococcus epidermidis staphylococcus hominis staphylococcus lugdunensis streptococcus mitis group streptococcus oralis streptococcus pneumoniae streptococcus salivarius efficacy for this organism was studied in fewer than 1 infections besivance tm besifloxacin ophthalmic suspension 6 is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria cdc coryneform group g corynebacterium pseudodiphtheriticum corynebacterium striatum haemophilus influenzae moraxella lacunata staphylococcus aureus staphylococcus epidermidis staphylococcus hominis staphylococcus lugdunensis streptococcus mitis group streptococcus oralis streptococcus pneumoniae streptococcus salivarius efficacy for this organism was studied in fewer than 1 infections 1
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB06771
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#provenance
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#pubinfo
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig
http://purl.org/nanopub/x/hasSignature
Q3AOSvy181nt9/E5LigGyVhIhPnHlCOad+AqWE/WGqLtMvsw0zcofcx67Vy051KDc4qII1XXxO7O+OEeqfoVhHQ+mxNhnUZDZGFX9Q3K2on9I0Vv+xIyYadJ/gXbUpWn1fqSwIRiOBF913pJTRmWEe1P4QiNr1cuCab++Jtwc8c=
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://purl.org/dc/terms/created
2021-06-12T15:52:50.916+02:00
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs